The key difference is how and where the medication is provided and supervised. Methadone maintenance is typically delivered through an opioid treatment program clinic with daily observed dosing, meaning patients usually go to the clinic each day for their dose. Suboxone maintenance is usually prescribed by a clinician in an office-based or outpatient setting and dispensed at a pharmacy, often with take-home doses after stabilization. This reflects how the two treatments are regulated and accessed, not a difference in the medications themselves (methadone vs buprenorphine/naloxone) in principle.

Diazepam is processed by the liver into several metabolites that themselves contribute to its overall effects. The usual metabolic pathway produces nordiazepam, temazepam, and oxazepam, all of which are active and can prolong sedation as diazepam is cleared from the body. Lorazepam, however, is not formed from diazepam’s metabolism; it is a separate benzodiazepine with its own distinct metabolic route, typically undergoing direct glucuronidation rather than oxidative metabolism. So lorazepam is not a metabolite of diazepam.

CAGE is a quick screening tool designed to flag possible problems with alcohol use and to indicate when a more thorough assessment is needed. It asks four brief questions about cutting down on drinking, annoyance from others' criticisms, guilt about drinking, and needing a morning “eye-opener.” If two or more answers are affirmative, it suggests potential alcohol misuse or dependence and prompts further evaluation. It’s not used to measure sleep quality, nicotine dependence, or blood pressure, and it isn’t a diagnostic tool by itself. Rather, its purpose is to efficiently identify individuals who may benefit from a detailed alcohol-use assessment or brief intervention in settings like primary care.

Alcohol-related liver injury usually affects multiple liver enzyme pathways, reflecting both hepatocellular damage and cholestatic effects, and it often shows a marker tied specifically to alcohol exposure. Transaminases (AST and ALT) indicate hepatocellular injury, with AST commonly higher than ALT in alcohol-related cases. GGT is frequently elevated and is particularly associated with chronic alcohol use. Alkaline phosphatase can also rise when there’s a cholestatic component or biliary involvement. So the pattern that best fits this scenario is elevations across AST, ALT, GGT, and alkaline phosphatase. In contrast, CK and LDH are not specific to the liver and are less informative for alcohol-related liver injury, and limiting to just ALT and AST or to a single marker would miss the broader, alcohol-associated pattern.